Successful use of indwelling tunneled catheters for the management of effusions in children with advanced cancer

Background Malignant pleural effusion (MPE) and ascites (MA) negatively impact quality of life of palliative patients. Treatment options are limited. This study's purpose is to examine the experience with indwelling tunneled catheters (ITCs) for management of MPE/MA in children with advanced ca...

Full description

Saved in:
Bibliographic Details
Published inPediatric blood & cancer Vol. 61; no. 6; pp. 1007 - 1012
Main Authors den Hollander, Barbara S., Connolly, Bairbre L., Sung, Lillian, Rapoport, Adam, Zwaan, C.M., Grant, Ronald M., Parra, Dimitri, Temple, Michael J.
Format Journal Article
LanguageEnglish
Published United States Blackwell Publishing Ltd 01.06.2014
Wiley Subscription Services, Inc
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Background Malignant pleural effusion (MPE) and ascites (MA) negatively impact quality of life of palliative patients. Treatment options are limited. This study's purpose is to examine the experience with indwelling tunneled catheters (ITCs) for management of MPE/MA in children with advanced cancer. Methods Children with MPE/MA who underwent ITC insertion (2007–2012) were retrospectively reviewed. Clinical, procedural, complication and outcome details were analyzed. Results PleurX® ITCs (n = 12) were inserted in eight patients (5–18 years) with sarcoma (11 MPE, 1 MA), achieving symptom relief and facilitating discharge home post ITC (median 2 days). Median survival following ITC was 51 days. There were two major complications: pain (n = 1), late site infection (n = 1), and five minor complications. Drainage ceased in four patients (pleurodesis/tumor progression). At time of death, six ITCs (five patients) were still in situ. Conclusions ITC appears to be a safe, effective treatment for MPE/MA in advanced pediatric cancer, achieving symptomatic relief and discharge home. Pediatr Blood Cancer 2014;61:1007–1012. © 2013 Wiley Periodicals, Inc.
AbstractList Background Malignant pleural effusion (MPE) and ascites (MA) negatively impact quality of life of palliative patients. Treatment options are limited. This study's purpose is to examine the experience with indwelling tunneled catheters (ITCs) for management of MPE/MA in children with advanced cancer. Methods Children with MPE/MA who underwent ITC insertion (2007–2012) were retrospectively reviewed. Clinical, procedural, complication and outcome details were analyzed. Results PleurX® ITCs (n = 12) were inserted in eight patients (5–18 years) with sarcoma (11 MPE, 1 MA), achieving symptom relief and facilitating discharge home post ITC (median 2 days). Median survival following ITC was 51 days. There were two major complications: pain (n = 1), late site infection (n = 1), and five minor complications. Drainage ceased in four patients (pleurodesis/tumor progression). At time of death, six ITCs (five patients) were still in situ. Conclusions ITC appears to be a safe, effective treatment for MPE/MA in advanced pediatric cancer, achieving symptomatic relief and discharge home. Pediatr Blood Cancer 2014;61:1007–1012. © 2013 Wiley Periodicals, Inc.
Malignant pleural effusion (MPE) and ascites (MA) negatively impact quality of life of palliative patients. Treatment options are limited. This study's purpose is to examine the experience with indwelling tunneled catheters (ITCs) for management of MPE/MA in children with advanced cancer. Children with MPE/MA who underwent ITC insertion (2007-2012) were retrospectively reviewed. Clinical, procedural, complication and outcome details were analyzed. PleurX® ITCs (n = 12) were inserted in eight patients (5-18 years) with sarcoma (11 MPE, 1 MA), achieving symptom relief and facilitating discharge home post ITC (median 2 days). Median survival following ITC was 51 days. There were two major complications: pain (n = 1), late site infection (n = 1), and five minor complications. Drainage ceased in four patients (pleurodesis/tumor progression). At time of death, six ITCs (five patients) were still in situ. ITC appears to be a safe, effective treatment for MPE/MA in advanced pediatric cancer, achieving symptomatic relief and discharge home.
BACKGROUNDMalignant pleural effusion (MPE) and ascites (MA) negatively impact quality of life of palliative patients. Treatment options are limited. This study's purpose is to examine the experience with indwelling tunneled catheters (ITCs) for management of MPE/MA in children with advanced cancer.METHODSChildren with MPE/MA who underwent ITC insertion (2007-2012) were retrospectively reviewed. Clinical, procedural, complication and outcome details were analyzed.RESULTSPleurX® ITCs (n = 12) were inserted in eight patients (5-18 years) with sarcoma (11 MPE, 1 MA), achieving symptom relief and facilitating discharge home post ITC (median 2 days). Median survival following ITC was 51 days. There were two major complications: pain (n = 1), late site infection (n = 1), and five minor complications. Drainage ceased in four patients (pleurodesis/tumor progression). At time of death, six ITCs (five patients) were still in situ.CONCLUSIONSITC appears to be a safe, effective treatment for MPE/MA in advanced pediatric cancer, achieving symptomatic relief and discharge home.
Background Malignant pleural effusion (MPE) and ascites (MA) negatively impact quality of life of palliative patients. Treatment options are limited. This study's purpose is to examine the experience with indwelling tunneled catheters (ITCs) for management of MPE/MA in children with advanced cancer. Methods Children with MPE/MA who underwent ITC insertion (2007-2012) were retrospectively reviewed. Clinical, procedural, complication and outcome details were analyzed. Results PleurX ITCs (n=12) were inserted in eight patients (5-18 years) with sarcoma (11 MPE, 1 MA), achieving symptom relief and facilitating discharge home post ITC (median 2 days). Median survival following ITC was 51 days. There were two major complications: pain (n=1), late site infection (n=1), and five minor complications. Drainage ceased in four patients (pleurodesis/tumor progression). At time of death, six ITCs (five patients) were still in situ. Conclusions ITC appears to be a safe, effective treatment for MPE/MA in advanced pediatric cancer, achieving symptomatic relief and discharge home. Pediatr Blood Cancer 2014;61:1007-1012. © 2013 Wiley Periodicals, Inc. [PUBLICATION ABSTRACT]
Author Grant, Ronald M.
Temple, Michael J.
Sung, Lillian
Connolly, Bairbre L.
Parra, Dimitri
Rapoport, Adam
Zwaan, C.M.
den Hollander, Barbara S.
Author_xml – sequence: 1
  givenname: Barbara S.
  surname: den Hollander
  fullname: den Hollander, Barbara S.
  organization: Division of Haematology/Oncology, The Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada
– sequence: 2
  givenname: Bairbre L.
  surname: Connolly
  fullname: Connolly, Bairbre L.
  email: Correspondence to: Bairbre L. Connolly, Image Guided Therapy, Diagnostic Imaging, Sick Kids Hospital, 555 University Avenue, Toronto, Ontario, Canada M5G 1X8., bairbre.connolly@sickkids.ca
  organization: Department of Diagnostic Imaging, Image Guided Therapy, The Hospital for Sick Children, University of Toronto, Ontario, Toronto, Canada
– sequence: 3
  givenname: Lillian
  surname: Sung
  fullname: Sung, Lillian
  organization: Division of Haematology/Oncology, The Hospital for Sick Children, University of Toronto, Ontario, Toronto, Canada
– sequence: 4
  givenname: Adam
  surname: Rapoport
  fullname: Rapoport, Adam
  organization: Paediatric Advanced Care Team, The Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada
– sequence: 5
  givenname: C.M.
  surname: Zwaan
  fullname: Zwaan, C.M.
  organization: Department of Pediatric Oncology/Haematology, Erasmus MC-Sophia Children's Hospital, University of Rotterdam, The Netherlands, Rotterdam
– sequence: 6
  givenname: Ronald M.
  surname: Grant
  fullname: Grant, Ronald M.
  organization: Division of Haematology/Oncology, The Hospital for Sick Children, University of Toronto, Ontario, Toronto, Canada
– sequence: 7
  givenname: Dimitri
  surname: Parra
  fullname: Parra, Dimitri
  organization: Department of Diagnostic Imaging, Image Guided Therapy, The Hospital for Sick Children, University of Toronto, Ontario, Toronto, Canada
– sequence: 8
  givenname: Michael J.
  surname: Temple
  fullname: Temple, Michael J.
  organization: Department of Diagnostic Imaging, Image Guided Therapy, The Hospital for Sick Children, University of Toronto, Ontario, Toronto, Canada
BackLink https://www.ncbi.nlm.nih.gov/pubmed/24376007$$D View this record in MEDLINE/PubMed
BookMark eNp1kctuFDEQRS2UiDxgwQ8gS2zCohM_2jZewiiESFGIBAiJjeV2lzMO3e7BbjPk7_FkklkgsapanHtk1z1Ce3GKgNArSk4pIexs1blT1mrCnqFDKlrRCELV3m4n-gAd5XxXUUnEu-fogLVcSULUIVp9Kc5Bzr4MuGTAk8ch9msYhhBv8VxihAF67Oy8hBlSxn5KuO54tNHewghx3mTA-5LDFHNNY7cMQ58g4nWYl9j2v210D4460gu07-2Q4eXjPEbfPp5_XXxqrj5fXC7eXzWOa8oaxRQnrfBCe6K16DrbCsdaxbueUM-sVky20lHPZU-lVW2nSN8R77VlTljGj9HJ1rtK068CeTZjyK7-y0aYSjZUUMW1UlRW9M0_6N1UUqyv21CyUozqSr3dUi5NOSfwZpXCaNO9ocRsajC1BvNQQ2VfPxpLN0K_I5_uXoGzLbAOA9z_32RuPiyelM02EfIMf3YJm34aqbgS5vv1hflBbmrF7NoQ_heYy6HP
CitedBy_id crossref_primary_10_1053_j_ro_2019_06_008
crossref_primary_10_1002_pbc_30238
crossref_primary_10_1016_j_thorsurg_2016_08_008
crossref_primary_10_1186_s12904_016_0116_5
crossref_primary_10_1002_pbc_29109
crossref_primary_10_1016_j_pcl_2014_04_010
Cites_doi 10.1055/s-2008-1039109
10.1503/cmaj.110392
10.1016/j.lungcan.2005.05.016
10.1089/jpm.2010.0539
10.1007/s10147-011-0312-5
10.1097/MCP.0b013e32832c6a8a
10.1378/chest.06-2353
10.1007/s00247-006-0392-y
10.1245/s10434-009-0691-2
10.1089/jpm.2009.0061
10.3322/caac.20073
10.1378/chest.129.2.362
10.1097/JTO.0b013e31820d614f
10.1016/j.athoracsur.2007.11.039
10.1097/01.RVI.0000094601.83406.e1
10.1007/S12325-010-0031-8
10.1183/09031936.01.00225601
10.1016/j.arbres.2009.09.009
10.1136/thx.2010.136994
10.1177/1479972311407216
ContentType Journal Article
Copyright 2013 Wiley Periodicals, Inc.
Copyright_xml – notice: 2013 Wiley Periodicals, Inc.
DBID BSCLL
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7T5
7TK
7TO
8FD
FR3
H94
K9.
P64
RC3
7X8
DOI 10.1002/pbc.24902
DatabaseName Istex
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
Immunology Abstracts
Neurosciences Abstracts
Oncogenes and Growth Factors Abstracts
Technology Research Database
Engineering Research Database
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
Biotechnology and BioEngineering Abstracts
Genetics Abstracts
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
Genetics Abstracts
Oncogenes and Growth Factors Abstracts
Technology Research Database
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
Immunology Abstracts
Engineering Research Database
Neurosciences Abstracts
Biotechnology and BioEngineering Abstracts
MEDLINE - Academic
DatabaseTitleList
MEDLINE
MEDLINE - Academic
Genetics Abstracts
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1545-5017
EndPage 1012
ExternalDocumentID 3276061521
10_1002_pbc_24902
24376007
PBC24902
ark_67375_WNG_Z0P2602N_0
Genre article
Journal Article
GroupedDBID ---
.3N
.GA
.Y3
05W
0R~
10A
123
1L6
1OC
31~
33P
3SF
3WU
4.4
4ZD
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52U
52V
52W
52X
53G
5VS
66C
6PF
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A01
A03
AAESR
AAEVG
AAHHS
AANLZ
AAONW
AASGY
AAWTL
AAXRX
AAZKR
ABCQN
ABCUV
ABEML
ABIJN
ABPPZ
ABPVW
ABQWH
ABXGK
ACAHQ
ACBWZ
ACCFJ
ACCZN
ACFBH
ACGFS
ACGOF
ACIWK
ACMXC
ACPOU
ACPRK
ACSCC
ACXBN
ACXQS
ADBBV
ADBTR
ADEOM
ADIZJ
ADKYN
ADMGS
ADOZA
ADXAS
ADZMN
AEEZP
AEIGN
AEIMD
AENEX
AEQDE
AEUQT
AEUYR
AFBPY
AFFPM
AFGKR
AFPWT
AFRAH
AFZJQ
AHBTC
AHMBA
AIACR
AITYG
AIURR
AIWBW
AJBDE
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
AMBMR
AMYDB
ATUGU
AZBYB
AZFZN
AZVAB
BAFTC
BDRZF
BFHJK
BHBCM
BMXJE
BROTX
BRXPI
BSCLL
BY8
C45
CS3
D-6
D-7
D-E
D-F
DCZOG
DPXWK
DR2
DRFUL
DRMAN
DRSTM
DU5
EBD
EBS
EJD
EMOBN
F00
F01
F04
F5P
FEDTE
FUBAC
G-S
G.N
GNP
GODZA
H.X
HBH
HF~
HGLYW
HHY
HHZ
HVGLF
HZ~
IX1
J0M
JPC
KBYEO
KQQ
LATKE
LAW
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
MEWTI
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
N04
N05
N9A
NF~
NNB
O66
O9-
OIG
OVD
P2W
P2X
P2Z
P4B
P4D
PQQKQ
Q.N
Q11
QB0
QRW
R.K
ROL
RWI
RX1
RYL
SUPJJ
SV3
TEORI
UB1
UDS
V2E
W8V
W99
WBKPD
WHWMO
WIH
WIJ
WIK
WJL
WOHZO
WQJ
WRC
WVDHM
WXI
WXSBR
XG1
XV2
~IA
~WT
CGR
CUY
CVF
ECM
EIF
NPM
AAMNL
AAYXX
ACRPL
ACYXJ
CITATION
7T5
7TK
7TO
8FD
FR3
H94
K9.
P64
RC3
7X8
ID FETCH-LOGICAL-c3912-7273045f59f0995bba45c2473bd01f2a972646c1f36d16a74b70db0ff9a2c5a23
IEDL.DBID DR2
ISSN 1545-5009
IngestDate Wed Dec 04 14:37:50 EST 2024
Tue Nov 19 04:19:28 EST 2024
Fri Dec 06 05:29:15 EST 2024
Sat Sep 28 08:05:33 EDT 2024
Sat Aug 24 00:51:27 EDT 2024
Wed Oct 30 09:56:50 EDT 2024
IsPeerReviewed true
IsScholarly true
Issue 6
Keywords ascites
pediatric oncology
catheters
pleural effusion
indwelling
malignant
Language English
License 2013 Wiley Periodicals, Inc.
http://onlinelibrary.wiley.com/termsAndConditions#vor
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c3912-7273045f59f0995bba45c2473bd01f2a972646c1f36d16a74b70db0ff9a2c5a23
Notes ArticleID:PBC24902
ark:/67375/WNG-Z0P2602N-0
istex:DD69CB5BA29DF9E82DAC46F6C84FEBF7A5DFF1BD
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PMID 24376007
PQID 1516397219
PQPubID 1036357
PageCount 6
ParticipantIDs proquest_miscellaneous_1517397716
proquest_journals_1516397219
crossref_primary_10_1002_pbc_24902
pubmed_primary_24376007
wiley_primary_10_1002_pbc_24902_PBC24902
istex_primary_ark_67375_WNG_Z0P2602N_0
PublicationCentury 2000
PublicationDate June 2014
PublicationDateYYYYMMDD 2014-06-01
PublicationDate_xml – month: 06
  year: 2014
  text: June 2014
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: Glenview
PublicationTitle Pediatric blood & cancer
PublicationTitleAlternate Pediatr Blood Cancer
PublicationYear 2014
Publisher Blackwell Publishing Ltd
Wiley Subscription Services, Inc
Publisher_xml – name: Blackwell Publishing Ltd
– name: Wiley Subscription Services, Inc
References Musani AI. Treatment options for malignant pleural effusion. [Internet]. Curr Opin Pulm Med 2009 15:380-387. Available from: http://www.ncbi.nlm.nih.gov/pubmed/19436206.
Matsubara N, Itoh K, Mukai H, et al. Long-term outcome of pleurodesis with OK-432 in metastatic breast cancer: A new risk model for success from an analysis of 75 cases. Int J Clin Oncol 2012; 17:470-476.
Suzuki K, Servais EL, Rizk NP, et al. Palliation and pleurodesis in malignant pleural effusion: The role for tunneled pleural catheters. J Thorac Oncol 2011; 6:762-767.
Fleming ND, Alvarez-Secord A, Von Gruenigen V, et al. Indwelling catheters for the management of refractory malignant ascites: A systematic literature overview and retrospective chart review. J Pain Symptom Manage 2007; 34:547-565.
Uzbeck MH, Almeida FA, Sarkiss MG, et al. Management of malignant pleural effusions. Adv Ther 2010; 27:334-347.
Chalhoub M, Harris K, Castellano M, et al. The use of the PleurX catheter in the management of non-malignant pleural effusions. Chronic Respir Dis 2011; 8:185-191.
Roberts ME, Neville E, Berrisford RG, et al. Management of a malignant pleural effusion: British Thoracic Society Pleural Disease Guideline 2010. Thorax 2010; 65:ii32-ii40.
Warren WH, Kalimi R, Khodadadian LM, et al. Management of malignant pleural effusions using the Pleur(x) catheter. Ann Thorac Surg 2008; 85:1049-1055.
Hoffer FA, Hancock ML, Hinds PS, et al. Pleurodesis for effusions in pediatric oncology patients at end of life. Pediatr Radiol 2007; 37:269-273.
Schneider T, Reimer P, Storz K, et al. Recurrent pleural effusion: Who benefits from a tunneled pleural catheter? Thorac Cardiovasc Surg 2009; 57:42-46.
Cases E, Seijo L, Disdier C, et al. Use of indwelling pleural catheter in the outpatient management of recurrent malignant pleural effusion. Arch Bronconeumol 2009; 45:591-596.
Tomlinson D, Bartels U, Gammon J, et al. Chemotherapy versus supportive care alone in pediatric palliative care for cancer: Comparing the preferences of parents and health care professionals. CMAJ 2011; 183:E1252-E1258.
Kriegel I, Daniel C. Falcou M-C, et al. Use of a subcutaneous implantable pleural port in the management of recurrent malignant pleurisy: Five-year experience based on 168 subcutaneous implantable pleural ports. J Palliat Med 2011; 14:829-834.
Janes SM, Rahman NM, Davies RJO, et al. Catheter-tract metastases associated with chronic indwelling pleural catheters. Chest 2007; 131:1232-1234.
Van den Toorn LM, Schaap E, Surmont VFM, et al. Management of recurrent malignant pleural effusions with a chronic indwelling pleural catheter. Lung Cancer 2005; 50:123-127.
Jemal A, Siegel R, Xu J, et al. Cancer statistics 2010. CA Cancer J Clin 60:277-300.
Lacy JH, Wieman TJ, Shively EH. Management of malignant ascites. Surg Gynecol Obstet 1984; 159:397-412.
Bazerbashi S, Villaquiran J, Awan MY, et al. Ambulatory intercostal drainage for the management of malignant pleural effusion: A single center experience. Ann Surg Oncol 2009; 16:3482-3487.
Tremblay A, Michaud G. Single-center experience with 250 tunnelled pleural catheter insertions for malignant pleural effusion. Chest 2006; 129:362-368.
Kufe D, Bast RCJ, Hait W, et al. Cancer medicine, 7th edition. Shelton, CT: People's Medical Publishing House; 2006. p 2328.
Monsky WL, Yoneda KY, MacMillan J, et al. Peritoneal and pleural ports for management of refractory ascites and pleural effusions: Assessment of impact on patient quality of life and hospice/home nursing care. J Palliat Med 2009; 12:811-817.
Antony VB, Loddenkemper R, Astoul P, et al. Management of malignant pleural effusions. Eur Respir J 2001; 18:402-419.
Omary RA, Bettmann MA, Cardella JF, et al. Quality improvement guidelines for the reporting, archiving of interventional radiology procedures. J Vasc Intervent Radiol 2003; 14:S293-S295.
2009; 12
2009; 45
2010; 65
2009; 57
2010; 27
2007; 131
1984; 159
2003; 14
2006
2012; 17
2008; 85
2001; 18
2005; 50
2011; 14
60
2011; 183
2011; 6
2006; 129
2007; 34
2009; 16
2011; 8
2009; 15
2007; 37
e_1_2_6_21_1
e_1_2_6_10_1
e_1_2_6_20_1
Jemal A (e_1_2_6_2_1); 60
Lacy JH (e_1_2_6_22_1) 1984; 159
e_1_2_6_9_1
e_1_2_6_8_1
e_1_2_6_19_1
e_1_2_6_5_1
e_1_2_6_4_1
e_1_2_6_7_1
e_1_2_6_13_1
Fleming ND (e_1_2_6_17_1) 2007; 34
e_1_2_6_14_1
e_1_2_6_24_1
e_1_2_6_3_1
e_1_2_6_11_1
e_1_2_6_23_1
e_1_2_6_12_1
Kufe D (e_1_2_6_6_1) 2006
e_1_2_6_18_1
e_1_2_6_15_1
e_1_2_6_16_1
References_xml – volume: 57
  start-page: 42
  year: 2009
  end-page: 46
  article-title: Recurrent pleural effusion: Who benefits from a tunneled pleural catheter
  publication-title: Thorac Cardiovasc Surg
– volume: 37
  start-page: 269
  year: 2007
  end-page: 273
  article-title: Pleurodesis for effusions in pediatric oncology patients at end of life
  publication-title: Pediatr Radiol
– volume: 15
  start-page: 380
  year: 2009
  end-page: 387
  article-title: Treatment options for malignant pleural effusion. [Internet]
  publication-title: Curr Opin Pulm Med
– volume: 17
  start-page: 470
  year: 2012
  end-page: 476
  article-title: Long‐term outcome of pleurodesis with OK‐432 in metastatic breast cancer: A new risk model for success from an analysis of 75 cases
  publication-title: Int J Clin Oncol
– volume: 60
  start-page: 277
  end-page: 300
  article-title: Cancer statistics 2010
  publication-title: CA Cancer J Clin
– volume: 183
  start-page: E1252
  year: 2011
  end-page: E1258
  article-title: Chemotherapy versus supportive care alone in pediatric palliative care for cancer: Comparing the preferences of parents and health care professionals
  publication-title: CMAJ
– volume: 27
  start-page: 334
  year: 2010
  end-page: 347
  article-title: Management of malignant pleural effusions
  publication-title: Adv Ther
– volume: 50
  start-page: 123
  year: 2005
  end-page: 127
  article-title: Management of recurrent malignant pleural effusions with a chronic indwelling pleural catheter
  publication-title: Lung Cancer
– volume: 65
  start-page: ii32
  year: 2010
  end-page: ii40
  article-title: Management of a malignant pleural effusion: British Thoracic Society Pleural Disease Guideline 2010
  publication-title: Thorax
– volume: 6
  start-page: 762
  year: 2011
  end-page: 767
  article-title: Palliation and pleurodesis in malignant pleural effusion: The role for tunneled pleural catheters
  publication-title: J Thorac Oncol
– volume: 18
  start-page: 402
  year: 2001
  end-page: 419
  article-title: Management of malignant pleural effusions
  publication-title: Eur Respir J
– start-page: 2328
  year: 2006
– volume: 16
  start-page: 3482
  year: 2009
  end-page: 3487
  article-title: Ambulatory intercostal drainage for the management of malignant pleural effusion: A single center experience
  publication-title: Ann Surg Oncol
– volume: 159
  start-page: 397
  year: 1984
  end-page: 412
  article-title: Management of malignant ascites
  publication-title: Surg Gynecol Obstet
– volume: 129
  start-page: 362
  year: 2006
  end-page: 368
  article-title: Single‐center experience with 250 tunnelled pleural catheter insertions for malignant pleural effusion
  publication-title: Chest
– volume: 131
  start-page: 1232
  year: 2007
  end-page: 1234
  article-title: Catheter‐tract metastases associated with chronic indwelling pleural catheters
  publication-title: Chest
– volume: 34
  start-page: 547
  year: 2007
  end-page: 565
  article-title: Indwelling catheters for the management of refractory malignant ascites: A systematic literature overview and retrospective chart review
  publication-title: J Pain Symptom Manage
– volume: 14
  start-page: S293
  year: 2003
  end-page: S295
  article-title: Quality improvement guidelines for the reporting, archiving of interventional radiology procedures
  publication-title: J Vasc Intervent Radiol
– volume: 8
  start-page: 185
  year: 2011
  end-page: 191
  article-title: The use of the PleurX catheter in the management of non‐malignant pleural effusions
  publication-title: Chronic Respir Dis
– volume: 45
  start-page: 591
  year: 2009
  end-page: 596
  article-title: Use of indwelling pleural catheter in the outpatient management of recurrent malignant pleural effusion
  publication-title: Arch Bronconeumol
– volume: 14
  start-page: 829
  year: 2011
  end-page: 834
  article-title: Use of a subcutaneous implantable pleural port in the management of recurrent malignant pleurisy: Five‐year experience based on 168 subcutaneous implantable pleural ports
  publication-title: J Palliat Med
– volume: 12
  start-page: 811
  year: 2009
  end-page: 817
  article-title: Peritoneal and pleural ports for management of refractory ascites and pleural effusions: Assessment of impact on patient quality of life and hospice/home nursing care
  publication-title: J Palliat Med
– volume: 85
  start-page: 1049
  year: 2008
  end-page: 1055
  article-title: Management of malignant pleural effusions using the Pleur(x) catheter
  publication-title: Ann Thorac Surg
– ident: e_1_2_6_24_1
  doi: 10.1055/s-2008-1039109
– ident: e_1_2_6_3_1
  doi: 10.1503/cmaj.110392
– ident: e_1_2_6_11_1
  doi: 10.1016/j.lungcan.2005.05.016
– ident: e_1_2_6_23_1
  doi: 10.1089/jpm.2010.0539
– ident: e_1_2_6_9_1
  doi: 10.1007/s10147-011-0312-5
– ident: e_1_2_6_10_1
  doi: 10.1097/MCP.0b013e32832c6a8a
– ident: e_1_2_6_21_1
  doi: 10.1378/chest.06-2353
– ident: e_1_2_6_20_1
  doi: 10.1007/s00247-006-0392-y
– ident: e_1_2_6_7_1
  doi: 10.1245/s10434-009-0691-2
– volume: 34
  start-page: 547
  year: 2007
  ident: e_1_2_6_17_1
  article-title: Indwelling catheters for the management of refractory malignant ascites: A systematic literature overview and retrospective chart review
  publication-title: J Pain Symptom Manage
  contributor:
    fullname: Fleming ND
– ident: e_1_2_6_15_1
  doi: 10.1089/jpm.2009.0061
– volume: 60
  start-page: 277
  ident: e_1_2_6_2_1
  article-title: Cancer statistics 2010
  publication-title: CA Cancer J Clin
  doi: 10.3322/caac.20073
  contributor:
    fullname: Jemal A
– ident: e_1_2_6_18_1
  doi: 10.1378/chest.129.2.362
– ident: e_1_2_6_12_1
  doi: 10.1097/JTO.0b013e31820d614f
– ident: e_1_2_6_16_1
  doi: 10.1016/j.athoracsur.2007.11.039
– start-page: 2328
  volume-title: Cancer medicine
  year: 2006
  ident: e_1_2_6_6_1
  contributor:
    fullname: Kufe D
– ident: e_1_2_6_13_1
  doi: 10.1097/01.RVI.0000094601.83406.e1
– ident: e_1_2_6_5_1
  doi: 10.1007/S12325-010-0031-8
– ident: e_1_2_6_8_1
  doi: 10.1183/09031936.01.00225601
– ident: e_1_2_6_19_1
  doi: 10.1016/j.arbres.2009.09.009
– volume: 159
  start-page: 397
  year: 1984
  ident: e_1_2_6_22_1
  article-title: Management of malignant ascites
  publication-title: Surg Gynecol Obstet
  contributor:
    fullname: Lacy JH
– ident: e_1_2_6_4_1
  doi: 10.1136/thx.2010.136994
– ident: e_1_2_6_14_1
  doi: 10.1177/1479972311407216
SSID ssj0026058
Score 2.149814
Snippet Background Malignant pleural effusion (MPE) and ascites (MA) negatively impact quality of life of palliative patients. Treatment options are limited. This...
Malignant pleural effusion (MPE) and ascites (MA) negatively impact quality of life of palliative patients. Treatment options are limited. This study's purpose...
Background Malignant pleural effusion (MPE) and ascites (MA) negatively impact quality of life of palliative patients. Treatment options are limited. This...
BACKGROUNDMalignant pleural effusion (MPE) and ascites (MA) negatively impact quality of life of palliative patients. Treatment options are limited. This...
SourceID proquest
crossref
pubmed
wiley
istex
SourceType Aggregation Database
Index Database
Publisher
StartPage 1007
SubjectTerms Adolescent
ascites
Ascites - etiology
Ascites - surgery
Ascites - therapy
Catheter-Related Infections - etiology
catheters
Catheters, Indwelling - adverse effects
Child
Child, Preschool
Drainage - instrumentation
Drainage - methods
Female
Hematology
Home Care Services
Humans
indwelling
Male
malignant
Oncology
Pain - etiology
Palliative Care
Paracentesis
Patient Acceptance of Health Care
pediatric oncology
Pediatrics
pleural effusion
Pleural Effusion, Malignant - etiology
Pleural Effusion, Malignant - surgery
Pleural Effusion, Malignant - therapy
Pleurodesis
Quality of Life
Recurrence
Retrospective Studies
Sarcoma - complications
Title Successful use of indwelling tunneled catheters for the management of effusions in children with advanced cancer
URI https://api.istex.fr/ark:/67375/WNG-Z0P2602N-0/fulltext.pdf
https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fpbc.24902
https://www.ncbi.nlm.nih.gov/pubmed/24376007
https://www.proquest.com/docview/1516397219
https://search.proquest.com/docview/1517397716
Volume 61
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnZ3ba9swFIcPpYOyl13aXbxlRStl7MWpLVtyTJ-29BIGDaVbWRkDYcnSS7ckJDaM_fU9R76UjBVKnyywJMu6fpKOfgLY57rkTvAyTEdChqkQZZhbMQpFInRuDA6KXnbxbConl-mXK3G1AYfdWZhGH6JfcKOW4ftrauCFXh3cioYutBni3MELScZJRuZ8Rxe9dBRhuj8Gh4QQCgSJTlUo4gd9yLWx6BFl65__geY6t_qB5-Qp_OyS3NibXA_rSg_N33_UHB_4T8_gSQuk7FNTg57Dhp1tw9ZZu-W-A4uvtb9T0dW_WL2ybO4YTuNpyQ8HPVbVZCdjS-blX0mpkyEFM3Sz371hDYWxztW0MLfC0Kw7Qc5oFZh1ZggYBz6WL-Dy5PjbeBK21zSEJslj5HMkIARDJ3KHuCm0LlJheJoluoxix4s8Q-iSJnaJLGNZZKnOolJHzuUFN6LgyUvYnM1n9jWwWMtRUrrI5s4Q6eRJLDByzp203EgZwF5XYGrRqHGoRneZK8w75fMugA--KHsfxfKazNcyob5PT9WP6BwrB5-qKIBBV9aqbbkrhQREe53YkQfwvn-NbY42UoqZndfeT0bgHGOCXjV1pP8YCTyS5n8AH31J351Odf557B1v7u_1LTxGYksbW7UBbFbL2r5DKqr0rq_-N5cxBWc
link.rule.ids 314,780,784,1375,27924,27925,46294,46718
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnZ3xS9wwFMcfojD9ZXNTt246MxHZLz3btEmv4C_O6W7TO2QqHoMRmjT5RXZ33F1h7K_fe-m1Q5kw9lMLTdI0yWs-fXn5FmCf65I7wcsw7QoZpkKUYW5FNxSJ0LkxOCl62cX-QPZu0i9DMVyCo2YvTK0P0TrcyDL8-5oMnBzSh39UQyfadPDjgZQkV9DcYwro-vi1FY8iUPcb4ZARQoEo0egKRfywzXpvNlqhhv35N9S8T65-6jl7Bt-bStcRJ3edaq475tcDPcf_fap1eLpgUnZcD6LnsGRHL-BJf7HqvgGTq8r_VhHLYNXMsrFj-CVPXj-c99i8olAZWzKvAEtinQxBmOE5-9HG1lAe61xFvrkZ5mbNJnJGjmDWRCJgGXiYbsLN2en1SS9c_KkhNEkeI6IjBCEbOpE7JE6hdZEKw9Ms0WUUO17kGXKXNLFLZBnLIkt1FpU6ci4vuBEFT7ZgeTQe2VfAYi27SekimztDsJMnscDCOXfSciNlAHtNj6lJLcihaullrrDtlG-7AA58X7YpiukdRbBlQt0OPqlv0SWODj5QUQDbTWerhfHOFEIQLXfiuzyAd-1lNDtaSylGdlz5NBmxc4wVelkPkvZmpPFIsv8BvPdd_Xg91eWHE3_y-t-T7sJq77p_oS4-D87fwBoCXFqHrm3D8nxa2R2EpLl-623hN_j-CYg
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnZ3bb9MwFIePpk2aeAHGNTCGQQjxki5xYqcWT7tQxmVVBUxME5IV314GbdU2EuKv5xynCRoCCfEUS7ETx_aJP9vHPwM848bxILhLy6GQaSmES5UXw1QUwihrsVOMsounY3lyVr49F-cb8LLbC9PqQ_QTbmQZ8X9NBj53Yf-XaOjc2AGOHUhIcquUXJFw_vGHXjuKOD3ug0NESAWSRCcrlPH9PumVzmiLyvX7n0jzKrjGnmd0A750eW4dTi4HzcoM7I_f5Bz_86NuwvU1kbKDtgntwIaf3oLt0_Wa-22Yf2zioYqh-cqapWezwHAcT3N-2OuxVUOOMt6xqP9KUp0MMZhhmH3rPWsojQ-hoZm5JaZm3RZyRtPArPNDwGfgZXEHzkavPh2dpOtzGlJbqBwBHREIyTAIFZA3hTF1KSwvq8K4LA-8VhVSl7R5KKTLZV2VpsqcyUJQNbei5sVd2JzOpv4-sNzIYeFC5lWwhDqqyAU-nPMgPbdSJvC0qzA9b-U4dCu8zDWWnY5ll8DzWJV9jHpxSf5rldCfx6_1RTbBxsHHOktgt6trvTbdpUYEosVO_JMn8KS_jUZHKyn11M-aGKcics4xQ_faNtK_jBQeSfQ_gRexpv-eTz05PIqBB_8e9TFsT45H-v2b8buHcA3prWz91nZhc7Vo_CMkpJXZi5bwE9SzCDc
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Successful+use+of+indwelling+tunneled+catheters+for+the+management+of+effusions+in+children+with+advanced+cancer&rft.jtitle=Pediatric+blood+%26+cancer&rft.au=den+Hollander%2C+Barbara+S&rft.au=Connolly%2C+Bairbre+L&rft.au=Sung%2C+Lillian&rft.au=Rapoport%2C+Adam&rft.date=2014-06-01&rft.eissn=1545-5017&rft.volume=61&rft.issue=6&rft.spage=1007&rft_id=info:doi/10.1002%2Fpbc.24902&rft_id=info%3Apmid%2F24376007&rft.externalDocID=24376007
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1545-5009&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1545-5009&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1545-5009&client=summon